Kazan (Volga region) Federal University, KFU
KAZAN
FEDERAL UNIVERSITY
 
DUPILUMAB FOR COPD WITH TYPE 2 INFLAMMATION INDICATED BY EOSINOPHIL COUNTS.
Form of presentationArticles in international journals and collections
Year of publication2023
Языкрусский
  • Fassakhov Rustem Salakhovich, author
  • Bibliographic description in the original language Bhatt SP, Rabe KF, Hanania NA, Vogelmeier CF, Cole J, Bafadhel M, Christenson SA, Papi A, Singh D, Laws E, Mannent LP, Patel N, Staudinger HW, Yancopoulos GD, Mortensen ER, Akinlade B, Maloney J, Lu X, Bauer D, Bansal A, Robinson LB, Abdulai RM; BOREAS Investigators. Dupilumab for COPD with Type 2 Inflammation Indicated by Eosinophil Counts. N Engl J Med. 2023 Jul 20;389(3):205-214. doi: 10.1056/NEJMoa2303951. Epub
    Keywords COPD, Dupilumab, Eosinophil
    The name of the journal NEW ENGLAND JOURNAL OF MEDICINE
    Please use this ID to quote from or refer to the card https://repository.kpfu.ru/eng/?p_id=321318&p_lang=2

    Full metadata record